Statins warning: Stopping treatment prematurely is 'not a wise choice' – risks
HEART disease comes in many varieties. From high cholesterol to high blood pressure, from atrial fibrillation to coronary heart disease, there are a variety of conditions which can affect the network of arteries and veins the body relies on. Of these, one of the most common is high cholesterol, an affliction which requires constant treatment and management. (Source: Daily Express - Health)
Source: Daily Express - Health - August 25, 2022 Category: Consumer Health News Source Type: news
Early Menopause Linked With Increased Risk of Heart Problems Early Menopause Linked With Increased Risk of Heart Problems
In a recent analysis of national health data, the risks for incident heart failure and incident atrial fibrillation increased as age at menopause decreased.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 25, 2022 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
U.S. FDA Approves IMBRUVICA ® (ibrutinib) as First and Only BTKi Treatment for Pediatric Patients with Chronic Graft-Versus-Host Disease
August 24, 2022 (HORSHAM, PA) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA® (ibrutinib) for the treatment of pediatric patients one year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy. This milestone marks the first pediatric indication for IMBRUVICA® and the introduction of a new oral suspension formulation for patients ages one to less than 12. IMBRUVICA® is now the first FDA-approved therapy for these younger patients who previously had no approv...
Source: Johnson and Johnson - August 24, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Atrial fibrillation: Amino acid found in some cheeses may induce ‘serious arrhythmias’
ATRIAL Fibrillation is rarely dangerous but it can lead to issues if left untreated. Although it is commonly caused by other conditions, some dietary sources are also known to trigger it. These may include certain types of cheese, according to various health bodies. (Source: Daily Express - Health)
Source: Daily Express - Health - August 24, 2022 Category: Consumer Health News Source Type: news
Atrial Cardiopathy Linked to 35% Higher Dementia Risk Atrial Cardiopathy Linked to 35% Higher Dementia Risk
The risk for dementia in people with atrial cardiopathy was increased even without atrial fibrillation or stroke, two known risk factors for dementia.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 19, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Left Atrial Appendage Occlusion Favored for Some A-Fib Patients
MONDAY, Aug. 15, 2022 -- For selected patients with atrial fibrillation (AF) and higher bleeding risk, left atrial appendage occlusion (LAAO) may be preferred over oral anticoagulation, according to research published online Aug. 16 in the Annals of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 15, 2022 Category: Pharmaceuticals Source Type: news
Worldwide Trends in Antithrombotic Therapy Prescribing for AF Worldwide Trends in Antithrombotic Therapy Prescribing for AF
How have oral anticoagulant prescribing patterns changed for patients with atrial fibrillation over the last decade?Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 15, 2022 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
' Obesity Paradox' in AF Challenged as Mortality Climbs With BMI'Obesity Paradox' in AF Challenged as Mortality Climbs With BMI
Mortality rose with body mass index in patients with new atrial fibrillation in a GARFIELD-AF analysis, which also examined BMI effects on bleeding with NOACs vs vitamin-K antagonists.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 12, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Formulary Restrictions May Worsen Atrial Fibrillation Outcomes
FRIDAY, Aug. 12, 2022 -- Limiting access to non-vitamin K antagonist oral anticoagulants (NOACs) may exacerbate underuse of anticoagulants and increase the risk for adverse health outcomes, such as stroke, among patients with newly diagnosed atrial... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 12, 2022 Category: Pharmaceuticals Source Type: news
Type of AF Among Predictors of DOAC Overdosing, Underdosing Type of AF Among Predictors of DOAC Overdosing, Underdosing
A fourth of patients received inappropriate doses of direct oral anticoagulants for atrial fibrillation in a prospective study, for reasons sometimes related to use or nonuse of certain other drugs.First Look (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 12, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Using Wearable Devices to Detect AF Is'Cost Effective'Using Wearable Devices to Detect AF Is'Cost Effective '
Screening for atrial fibrillation using wrist-worn devices is cost-effective compared with no screening or screening for AF using traditional methods, a new study concludes.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 8, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Screening for A-Fib Using Wearable Devices May Be Cost-Effective
FRIDAY, Aug. 5, 2022 -- Screening for atrial fibrillation (AF) using wearable devices seems to be cost-effective compared with no screening or screening using traditional methods, according to a study published online Aug. 5 in JAMA Health... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 5, 2022 Category: Pharmaceuticals Source Type: news
Premature Menopause May Increase Risk for Heart Failure, A-Fib
FRIDAY, Aug. 5, 2022 -- A history of premature menopause is associated with an increased incidence of heart failure and atrial fibrillation (AF), according to a study published online Aug. 4 in the European Heart Journal.
Jean Shin, from the Korea... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 5, 2022 Category: Pharmaceuticals Source Type: news
European Commission Approves IMBRUVICA ® (ibrutinib) in a Fixed-Duration Combination Regimen for Adult Patients with Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
BEERSE, BELGIUM, 4 August 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission granted marketing authorisation for the expanded use of IMBRUVICA® (ibrutinib) in an all-oral, fixed-duration (FD) treatment combination with venetoclax (I+V) for adults with previously untreated chronic lymphocytic leukaemia (CLL). The approval is based on the pivotal Phase 3 GLOW study that demonstrated superior progression-free survival (PFS) in patients treated with I+V versus chlorambucil-obinutuzumab (Clb+O), and the FD cohort of the Phase 2 CAPTIVATE study, which showed deep ...
Source: Johnson and Johnson - August 4, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
Migraine With Aura ID'd as Independent Risk Factor for A-Fib
WEDNESDAY, Aug. 3, 2022 -- Patients with migraine with aura (MwA) have significantly higher artificial intelligence-enabled electrocardiogram (AI-ECG) atrial fibrillation (AF) prediction model output, according to a study published online June 8 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 3, 2022 Category: Pharmaceuticals Source Type: news
